Suppr超能文献

慢性阻塞性肺疾病中步行速度的测量:30米步行试验的重测信度及与6分钟步行试验的比较

Measuring walking speed in COPD: test-retest reliability of the 30-metre walk test and comparison with the 6-minute walk test.

作者信息

Andersson Mikael, Moberg Linda, Svantesson Ulla, Sundbom Ann, Johansson Henrik, Emtner Margareta

机构信息

Department of Neuroscience, Uppsala University, Uppsala, Sweden.

出版信息

Prim Care Respir J. 2011 Dec;20(4):434-40. doi: 10.4104/pcrj.2011.00082.

Abstract

AIMS

To examine test-retest reliability of the 30-metre walk test (30mWT) in patients with chronic obstructive pulmonary disease (COPD) and to compare the 30mWT with the 6-minute walk test (6MWT).

METHODS

Forty-nine subjects with stable COPD were included. The 30mWT consists of walking at different walking intensities over a distance of 30 metres - self-selected speed (ss-30mWT) and maximal speed (ms-30mWT). The test was conducted twice and the time to walk 30 metres was recorded. The 6MWT was performed in duplicate on the same day.

RESULTS

Test-retest reliability was high: intraclass correlation coefficient (ICC(2.1)) = 0.93 (95% CI 0.87 to 0.97) for maximal walking speed and 0.87 (95% CI 0.78 to 0.93) for self-selected walking speed. Both maximal and self-selected speed had a standard error of measurement (SEM) of 0.07 m/s and SEM% was 4.4 for maximal speed and 5.9 for self-selected speed. The correlation, criterion validity, between ms-30mWT and the 6MWT was r=0.78 (p<0.001). Heart rate, dyspnoea, exertion and oxygen saturation were more affected after the 6MWT than after the 30mWT (p<0.001).

CONCLUSIONS

The 30mWT is a reliable submaximal test that is easy to perform and can be used to measure physical function (walking ability) in patients with COPD. It may be well suited for primary care settings.

摘要

目的

检验慢性阻塞性肺疾病(COPD)患者30米步行试验(30mWT)的重测信度,并将30mWT与6分钟步行试验(6MWT)进行比较。

方法

纳入49例稳定期COPD患者。30mWT包括在30米的距离内以不同步行强度行走——自选速度(ss - 30mWT)和最大速度(ms - 30mWT)。该测试进行两次,记录步行30米的时间。6MWT在同一天重复进行两次。

结果

重测信度较高:最大步行速度的组内相关系数(ICC(2.1))= 0.93(95%可信区间0.87至0.97),自选步行速度的组内相关系数为0.87(95%可信区间0.78至0.93)。最大速度和自选速度的测量标准误(SEM)均为0.07 m/s,最大速度的SEM%为4.4,自选速度的SEM%为5.9。ms - 30mWT与6MWT之间的相关性(效标效度)为r = 0.78(p<0.001)。6MWT后心率、呼吸困难、劳累和血氧饱和度比30mWT后受影响更大(p<0.001)。

结论

30mWT是一种可靠的次极量测试,易于实施,可用于测量COPD患者的身体功能(步行能力)。它可能非常适合基层医疗环境。

相似文献

10
Determinants of gait speed in COPD.COPD 患者步态速度的决定因素。
Chest. 2014 Jul;146(1):104-110. doi: 10.1378/chest.13-2017.

引用本文的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验